US BANCORP \DE\ - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 86 filers reported holding UTAH MED PRODS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$90,300
-9.6%
1,050
-2.1%
0.00%
Q2 2023$99,910
-6.8%
1,072
-5.2%
0.00%
Q1 2023$107,185
-23.8%
1,131
-19.2%
0.00%
Q4 2022$140,641
+18.2%
1,3990.0%0.00%
Q3 2022$119,000
-4.0%
1,399
-3.0%
0.00%
Q2 2022$124,000
-1.6%
1,442
+2.9%
0.00%
Q1 2022$126,000
-11.9%
1,401
-2.0%
0.00%
Q4 2021$143,000
-0.7%
1,430
-8.1%
0.00%
Q3 2021$144,000
+9.1%
1,5560.0%0.00%
Q2 2021$132,000
-9.6%
1,556
-7.7%
0.00%
Q1 2021$146,000
-17.5%
1,685
-20.0%
0.00%
Q4 2020$177,000
-17.3%
2,105
-21.4%
0.00%
-100.0%
Q3 2020$214,000
-12.3%
2,679
-2.7%
0.00%0.0%
Q2 2020$244,000
-22.5%
2,752
-17.7%
0.00%0.0%
Q1 2020$315,000
-28.4%
3,342
-18.1%
0.00%0.0%
Q4 2019$440,000
-50.0%
4,081
-55.5%
0.00%
-50.0%
Q3 2019$880,000
-7.8%
9,178
-7.9%
0.00%
-33.3%
Q2 2019$954,000
+7.3%
9,967
-1.1%
0.00%0.0%
Q1 2019$889,000
+2.3%
10,079
-3.7%
0.00%0.0%
Q4 2018$869,000
-11.9%
10,466
-0.0%
0.00%0.0%
Q3 2018$986,000
-18.0%
10,469
-4.1%
0.00%
-25.0%
Q2 2018$1,203,000
+0.3%
10,913
-10.0%
0.00%0.0%
Q1 2018$1,199,000
+19.7%
12,129
-1.5%
0.00%
+33.3%
Q4 2017$1,002,000
+11.7%
12,314
+1.0%
0.00%0.0%
Q3 2017$897,000
-1.9%
12,194
-3.4%
0.00%0.0%
Q2 2017$914,000
+3.9%
12,624
-10.7%
0.00%0.0%
Q1 2017$880,000
-20.4%
14,139
-6.9%
0.00%
-25.0%
Q4 2016$1,105,000
+18.1%
15,180
-2.9%
0.00%
+33.3%
Q3 2016$936,000
-21.9%
15,640
-17.9%
0.00%
-40.0%
Q2 2016$1,199,000
-15.1%
19,044
-15.6%
0.01%
-16.7%
Q1 2016$1,412,000
-20.2%
22,572
-25.3%
0.01%
-14.3%
Q4 2015$1,769,000
+3.8%
30,225
-4.4%
0.01%0.0%
Q3 2015$1,705,000
-15.8%
31,629
-6.8%
0.01%
-12.5%
Q2 2015$2,024,000
-0.4%
33,938
-0.1%
0.01%0.0%
Q1 2015$2,033,000
+0.6%
33,964
+1.0%
0.01%0.0%
Q4 2014$2,021,000
+25.0%
33,641
+1.5%
0.01%
+14.3%
Q3 2014$1,617,000
-5.8%
33,147
-0.7%
0.01%0.0%
Q2 2014$1,717,000
-14.5%
33,377
-3.9%
0.01%
-12.5%
Q1 2014$2,008,000
-0.5%
34,725
-1.7%
0.01%0.0%
Q4 2013$2,019,000
-12.1%
35,312
-8.6%
0.01%
-20.0%
Q3 2013$2,297,000
+10.5%
38,645
+1.0%
0.01%
+11.1%
Q2 2013$2,078,00038,2750.01%
Other shareholders
UTAH MED PRODS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Penn Mutual Asset Management, LLC 30,283$2,822,3762.54%
Clean Yield Group 30,703$2,861,5201.18%
RICE HALL JAMES & ASSOCIATES, LLC 112,999$10,531,4680.60%
Ranger Investment Management 78,681$7,333,0690.44%
Watershed Asset Management, L.L.C. 2,515$234,3980.29%
ISTHMUS PARTNERS, LLC 20,937$1,951,3280.27%
Cardinal Capital Management 11,309$1,057,3250.21%
GLOBEFLEX CAPITAL L P 9,338$870,3020.10%
Penobscot Investment Management Company, Inc. 4,000$372,8000.06%
JAMES INVESTMENT RESEARCH INC 4,292$400,0140.05%
View complete list of UTAH MED PRODS INC shareholders